Wearables raise millions as guests revolt against being tracked
Global Wellness Summit's latest roundup captures a fault line running through retreat programming. Hilo, the Fitbit-style blood-pressure wearable, added $19M to its Series B (past $119M raised), and Casana closed $46M for a health-monitoring toilet seat — real capital chasing continuous biometric tracking. At the same moment, GWS flags a rising "unquantified self" backlash: guests wanting out from under constant health data, toward programs built on trusting the body rather than measuring it. For advisors this isn't a trend to bet on either side of — it's a client-intake question. Sensei-style destination spas built around continuous monitoring suit data-driven clients; digital-detox-positioned retreats suit those fatigued by tracking. Ask which camp a client falls into before booking, rather than assuming more sensors and dashboards automatically mean a better-matched program.
"Skin longevity" spreads across spa menus — with a washing warning attached
Global Wellness Summit's Trendium tracks "skin longevity" overtaking anti-aging as the operative term on beauty and medical-wellness menus, backed by real money: Beiersdorf's $100M+ VC fund, Rapalogix's $20M raise, and L'Oréal's new Cell BioPrint diagnostic. The framing — cellular-level, diagnostic-driven protocols rather than surface treatments — is migrating from beauty labs into the longevity-clinic space advisors already sell, at operators like Clinique La Prairie, Lanserhof, and SHA Wellness. But GWS's own trend-watchers are warning about "longevity washing": properties adopting the vocabulary of cellular science without the clinical backing to support it. Before positioning "skin longevity" as a client-facing differentiator, advisors should press suppliers for the actual evidence behind the claim — a named diagnostic, a published protocol, a screening step — rather than taking the terminology at face value.